Related Experiment Video
Updated: Jan 24, 2026
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
Exposure time versus cytotoxicity for anticancer agents
David M Evans1, Jianwen Fang2, Thomas Silvers1
1Molecular Pharmacology Group, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Purpose:
Time is a critical factor in drug action. The duration of inhibition of the target or residence time of the drug molecule on the target often guides drug scheduling.
Methods:
The effects of time on the concentration-dependent cytotoxicity of approved and investigational agents [300 compounds] were examined in the NCI60 cell line panel in 2D at 2, 3, 7 and in 3D 11 days.
Results:
There was a moderate positive linear relationship between data from the 2-day NCI60 screen and the 3-, 7- and 11-day and a strong positive linear relationship between 3-, 7- and 11-day luminescence screen IC50s by Pearson correlation analysis. Cell growth inhibition by agents selective for a specific cell cycle phase plateaued when susceptible cells were growth inhibited or killed. As time increased the depth of cell growth inhibition increased without change in the IC50. DNA interactive agents had decreasing IC50s with increasing exposure time. Epigenetic agents required longer exposure times; several were only cytotoxic after 11 days' exposure. For HDAC inhibitors, time had little or no effect on concentration response. There were potency differences amongst the three BET bromodomain inhibitors tested, and an exposure duration effect. The PARP inhibitors, rucaparib, niraparib, and veliparib reached IC50s < 10 microM in some cell lines after 11 days.
Conclusions:
The results suggest that variations in compound exposure time may reflect either mechanism of action or compound chemical half-life. The activity of slow-acting compounds may optimally be assessed in spheroid models that can be monitored over prolonged incubation times.
Insights
Drug exposure time significantly impacts cell cytotoxicity, with some agents like epigenetic drugs requiring longer incubation periods for optimal assessment. Understanding this time-dependency is crucial for effective drug scheduling and development.
Area of Science:
- Pharmacology
- Drug Discovery
- Cancer Research
Background:
- Drug efficacy and scheduling are critically influenced by the duration of target inhibition or drug residence time.
- Understanding the impact of time on drug action is essential for optimizing therapeutic strategies.
Purpose of the Study:
- To investigate the effects of varying exposure times on the concentration-dependent cytotoxicity of 300 approved and investigational agents.
- To compare drug activity in 2D cell cultures over 2, 3, and 7 days versus 3D spheroid models over 11 days.
Main Methods:
- Utilized the NCI60 cell line panel for drug screening in both 2D and 3D culture models.
- Assessed cytotoxicity across multiple time points (2, 3, 7, and 11 days) to determine concentration-response relationships.
- Employed Pearson correlation analysis to compare IC50 values across different incubation durations.
Main Results:
- A moderate to strong positive linear relationship was observed between shorter and longer incubation times for IC50 values.
- Cell growth inhibition plateaued for cell cycle-specific agents as susceptible cells were inhibited or killed.
- DNA-interactive agents showed decreasing IC50 values with increased exposure time, while epigenetic agents and some PARP inhibitors required longer incubation (up to 11 days) for significant cytotoxicity.
Conclusions:
- Variations in compound exposure time can indicate distinct mechanisms of action or differences in chemical half-life.
- Prolonged incubation times in 3D spheroid models are optimal for assessing the activity of slow-acting compounds.
- The study highlights the importance of considering exposure duration in drug development and scheduling.
Related Concept Videos
01:29Subviral Agents
01:27Air-entraining Agents
01:19Masking and Demasking Agents
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
01:06Oral Hypoglycemic Agents: Glinides
01:29Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...